Disease outcomes in the absence of a relapse in patients with neuromyelitis optica spectrum disorder

被引：0
|
作者：
Royston, M. [1 ]
Kielhorn, A. [1 ]
Tanvir, I. [1 ]
Sabatella, G. [1 ]
机构：
[1] Alex Pharmaceut, Boston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P027
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] Factors associated with disease relapse rate in the Neuromyelitis optica spectrum disorder
    Li, Hai-yun
    Cui, Cai-san
    Yang, Hui-min
    Jiang, Wen-jing
    Yang, Xiang-dong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (10) : 1114 - 1119
  • [2] Clinical and therapeutic predictors of relapse and disability outcomes in neuromyelitis optica spectrum disorder
    Kunchok, A.
    Malpas, C.
    Horakova, D.
    Havrdova, E.
    Alroughani, R.
    Terzi, M.
    Yamout, B.
    Karabudak, R.
    Boz, C.
    Ozakbas, S.
    Olascoagam, J.
    Simon, M.
    Granellau, F.
    McCombe, P.
    Csepanym, T.
    Bergamaschi, R.
    Fragoso, Y.
    Al-Harbin, T.
    Turkoglu, R.
    Lechner-Scott, J.
    Laureys, G.
    Pucci, E.
    Sola, P.
    Ferraro, D.
    Altintas, A.
    Grand'Maison, F.
    Izquierdo, G.
    Eichau, S.
    Lugaresi, A.
    Marriott, M.
    Kister, I.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 535 - 537
  • [3] Pregnancy outcomes in neuromyelitis optica spectrum disorder
    Vishnevetsky, A.
    Levy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 140 - 140
  • [4] Prognostic factors for first relapse in Thai patients with neuromyelitis optica spectrum disorder
    Suksuchano, K.
    Aungsumart, S.
    Apiwattanakul, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1063 - 1064
  • [5] Factors affecting relapse rate in patients with neuromyelitis optica spectrum disorder Reply
    Tahara, Masayuki
    Oeda, Tomoko
    Sawada, Hideyuki
    LANCET NEUROLOGY, 2020, 19 (07): : 564 - 564
  • [6] Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy
    Ma, Xiaoyu
    Kermode, Allan G.
    Hu, Xueqiang
    Qiu, Wei
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [7] Clinical determinants and therapeutic modifiers of relapse and disability outcomes in neuromyelitis optica spectrum disorder
    Kunchok, Amy
    Malpas, Charles
    Nytrova, Petra
    Havrdova, Eva
    Alroughani, Raed
    Terzi, Murat
    Yamout, Bassem
    Hor, Jyh Yung
    Karabudak, Rana
    Boz, Cavit
    Ozakbas, Serkan
    Olascoaga Urtaza, Francisco Javier
    Simo, Magdolna
    Granella, Franco
    Patti, Francesco
    McCombe, Pamela
    Csepany, Tunde
    Singhal, Bhim
    Bergamaschi, Roberto
    Fragoso, Yara
    Al-Harbi, Talal
    Turkoglu, Recai
    Lechner-Scott, Jeannette
    Laureys, Guy
    Oreja-Guevara, Celia
    Pucci, Eugenio
    Sola, Patrizia
    Ferraro, Diana
    Altintas, Ayse
    Soysal, Aysun
    Vucic, Steve
    Grand-Maison, Francois
    Eichau Madueno, Sara
    Izquierdo Ayuso, Guillermo
    Lugaresi, Alessandra
    Onofrj, Marco
    Trojano, Maria
    Marriott, Mark
    Butzkueven, Helmut
    Kister, Ilya
    Kalincik, Tomas
    NEUROLOGY, 2019, 92 (15)
  • [8] AzathioprineSevere relapse in neuromyelitis optica spectrum disorder: case report
    Reactions Weekly, 2017, 1633 (1) : 101 - 101
  • [9] Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
    Uzawa, Akiyuki
    Mori, Masahiro
    Masuda, Saeko
    Aoe, Kazuhiko
    Kuwabara, Satoshi
    CASE REPORTS IN MEDICINE, 2011, 2011
  • [10] Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review
    Etemadifar, Masoud
    Alaei, Seyyed-Ali
    Akaishi, Tetsuya
    Salari, Mehri
    Norouzi, Mahdi
    Samadzadeh, Sara
    Paul, Friedemann
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
12345